CosyntropinHormone TherapySafety Rating 9/10

Primary research areaAdrenal insufficiency diagnostic test

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range0.25 mg IV or IM for stimulation test
AdministrationIV or IM injection
Safety9/10 · FDA-approved (Cortrosyn)
NCAA D1Banned

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Overview

About Cosyntropin

Mechanism of action

Synthetic ACTH (1-24); stimulates cortisol production for adrenal function assessment

Safety profile

Mild nausea, rare allergic reactions; diagnostic use · Diagnostic use only; very short exposure; minimal side effects

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Cosyntropin

Failed to fetch